Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

HoxB8 requires its Pbx-interaction motif to block differentiation of primary myeloid progenitors and of most cell line models of myeloid differentiation

Abstract

HoxB8 was the first homeobox gene identified as a cause of leukemia. In murine WEHI3B acute myeloid leukemia (AML) cells, proviral integration leads to the expression of both HoxB8 and Interleukin (IL-3). Enforced expression of HoxB8 blocks differentiation of factor-dependent myeloid progenitors, while IL-3 co-expression induces autocrine proliferation and overt leukemogenicity. Previously, we demonstrated that HoxB8 binds DNA cooperatively with members of the Pbx family of transcription factors, and that HoxB8 makes contact with the Pbx homeodomain through a hexameric sequence designated the Pbx-interaction motif (PIM). E2a-Pbx1, an oncogenic derivative of Pbx1, both retains its ability to heterodimerize with Hox proteins and arrest myeloid differentiation. This observation prompts the question of whether E2a-Pbx1 and Hox oncoproteins use endogenous Hox and Pbx proteins, respectively, to target a common set of cellular genes. Here, we use four different models of neutrophil and macrophage differentiation to determine whether HoxB8 needs to bind DNA or Pbx cofactors in order to arrest myeloid differentiation. The ability of HoxB8 to bind DNA or to bind Pbx was essential (1) to block differentiation of factor-dependent myeloid progenitors from primary marrow; (2) to block IL-6-induced monocytic differentiation of M1-AML cells; and (3) to block granulocytic differentiation of GM-CSF-dependent ECoM-G cells. However, while DNA-binding was required, the HoxB8 Pbx-interaction motif was unnecessary for preventing macrophage differentiation of ECoM-M cells. We conclude that HoxB8 prevents differentiation by directly influencing cellular gene expression, and that the genetic context within a cell dictates whether the effect of HoxB8 is dependent on a physical interaction with Pbx proteins.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Blatt C, Aberdam D, Schwartz R, Sachs L . 1988 EMBO J. 7: 4283–4290

  • Borrow J, Shearman AM, Stanton VP, Becher R, Collins T, Williams AJ, Dube I, Katz F, Kwong YL, Morris C, Ohyashiki K, Toyama K, Rowley J, Housman DE . 1996 Nat. Genet. 12: 159–167

  • Calvo KR, Knoepfler P, McGrath S, Kamps MP . 1999 Oncogene 18: 8033–8043

  • Calvo KR, Sykes D, Pasillas M, Kamps MP . 2000 Mol. Cell. Biol. 20: 3274–3285

  • Care A, Valtieri M, Mattia G, Meccia E, Masella B, Luchetti L, Felicetti F, Colombo MP, Peschle C . 1999 Oncogene 18: 1993–2001

  • Chang CP, Brocchieri L, Shen WF, Largman C, Cleary ML . 1996 Mol. Cell. Biol. 16: 1734–1745

  • Chang CP, Jacobs Y, Nakamura T, Jenkins NA, Copeland NG, Cleary ML . 1997 Mol. Cell. Biol. 17: 5679–5687

  • Chen J, Ruley HE . 1998 J. Biol. Chem. 273: 24670–24675

  • Dedera DA, Waller EK, Lebrun DP, Sen-Majumdar A, Stevens ME, Barsh GS, Cleary ML . 1993 Cell 74: 833–843

  • Di Rocco G, Mavilio F, Zappavigna V . 1997 EMBO J. 16: 3644–3654

  • Downing JR . 1999 Br. J. Haematol. 106: 296–308

  • Golub TT, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD, Lander ES . 1999 Science 286: 531–537

  • Goudet G, Delhalle S, Biemar F, Martial JA, Peers B . 1999 J. Biol. Chem. 274: 4067–4073

  • Hatano M, Roberts CW, Minden M, Crist WM, Korsmeyer SJ . 1991 Science 253: 79–82

  • Hawley RG, Fong AZ, Lu M, Hawley TS . 1994 Oncogene 9: 1–12

  • Izon DJ, Rozenfeld S, Fong ST, Komuves L, Largman C, Lawrence HJ . 1998 Blood 92: 383–393

  • Jacobs Y, Schnabel CA, Cleary ML . 1999 Mol. Cell. Biol. 19: 5134–5142

  • Kamps MP, Baltimore D . 1993 Mol. Cell. Biol. 13: 351–357

  • Kamps MP, Look T, Baltimore D . 1991 Genes Dev. 5: 358–368

  • Kamps MP, Wright DD . 1994 Oncogene 9: 3159–3166

  • Kasper LH, Brindle PK, Schnabel CA, Pritchard CE, Cleary ML, Van Deursen JM . 1999 Mol. Cell. Biol. 19: 764–776

  • Knoepfler PS, Calvo KR, Chen H, Antonarakis SE, Kamps MP . 1997 Proc. Natl. Acad. Sci. USA 94: 14553–14558

  • Knoepfler PS, Kamps MP . 1995 Mol. Cell. Biol. 15: 5811–5819

  • Knoepfler PS, Lu Q, Kamps MP . 1996 Nucleic Acids Res. 24: 2288–2294

  • Kroon E, Krosl J, Thorsteinsdottir U, Baban S, Buchberg AM, Sauvageau G . 1998 EMBO J. 17: 3714–3725

  • Krosl J, Baban S, Krosl G, Rozenfeld S, Largman C, Sauvageau G . 1998 Oncogene 16: 3403–3412

  • Krumlauf R . 1994 Cell 78: 191–201

  • Lawrence HJ, Helgason CD, Sauvageau G, Fong S, Izon DJ, Humphries RK, Largman C . 1997 Blood 89: 1922–1930

  • Lawrence HF, Sauvageau G, Humphries RK, Largman C . 1996 Stem Cells 14: 281–291

  • Lewis EB . 1978 Nature 276: 565–570

  • Lu Q, Kamps MP . 1996 Mol. Cell. Biol. 16: 1632–1640

  • Lu Q, Kamps MP . 1997 Oncogene 14: 75–83

  • McGinnis W, Krumlauf R . 1992 Cell 68: 283–302

  • Nakamura T, Largaespada DA, Lee MP, Johnson LA, Ohyashiki K, Toyama K, Chen SJ, Willman CL, Chen IM, Feinberg AP, Jenkins NA, Copeland NG, Shaughnessy JD . 1996 Nat. Genet. 12: 154–158

  • Nakamura T, Largaespada DA, Shaughnessy JD, Jenkins NA, Copeland NG . 1996 Nat. Genet. 12: 149–153

  • Passner JM, Ryoo HD, Shen L, Mann RS, Aggarwal AK . 1999 Nature 397: 714–719

  • Peers B, Sharma S, Johnson T, Kamps MP, Montminy M . 1995 Mol. Cell. Biol. 15: 7091–7097

  • Perkins A, Kongsuwan K, Visvader J, Adams JM, Cory S . 1990 Proc. Natl. Acad. Sci. USA 87: 8398–8402

  • Piper DE, Batchelor AH, Chang C, Cleary ML, Wolberger C . 1999 Cell 96: 587–597

  • Popperl H, Bienz M, Studer M, Chan SK, Aparicio S, Brenner S, Mann RS, Krumlauf R . 1995 Cell 81: 1031–1042

  • Sauvageau G, Thorsteinsdottir U, Eaves CJ, Lawrence HF, Largman C, Lansdorp PM, Humphries RK . 1995 Genes Dev. 9: 1753–1765

  • Sauvageau G, Thorsteinsdottir U, Hough MR, Hugo P, Lawrence HJ, Largman C, Humphries RK . 1997 Immunity 6: 13–22

  • Sykes DB, Kamps MK . 2001 Blood in press

  • Tora L, Mullick A, Metzger D, Ponglikitmongkol M, Park I, Chambon P . 1989 EMBO J. 8: 1981–1986

  • Thorsteinsdottir U, Sauvageau G, Hough MR, Dragowska W, Lansdorp PM, Lawrence HJ, Largmen C, Humphries RK . 1997 Mol. Cell. Biol. 17: 495–505

  • Vogt PK, Bos TJ . 1990 Adv. Cancer Res. 55: 1–35

  • Yaron Y, McAdara JK, Lynch M, Hughes E, Gasson JC . 2001 J. Immunol. 166: 5058–5067

Download references

Acknowledgements

This work was supported by Public Health Services grant CA56876.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mark P Kamps.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Knoepfler, P., Sykes, D., Pasillas, M. et al. HoxB8 requires its Pbx-interaction motif to block differentiation of primary myeloid progenitors and of most cell line models of myeloid differentiation. Oncogene 20, 5440–5448 (2001). https://doi.org/10.1038/sj.onc.1204710

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204710

Keywords

This article is cited by

Search

Quick links